State Street’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History

State Street’s Portfolio CYT Stock Details CYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-46,153	Closed	-$140K	–	4433
2023 Q4	$140K	Hold	46,153	–	–	﹤0.01%	3972
2023 Q3	$131K	Buy	46,153 +22,300	+93%	+$61.4K	﹤0.01%	4043
2023 Q2	$62K	Hold	23,853	–	–	﹤0.01%	4363
2023 Q1	$43.4K	Hold	23,853	–	–	﹤0.01%	4538
2022 Q4	$39.4K	Hold	23,853	–	–	﹤0.01%	4612
2022 Q3	$46K	Hold	23,853	–	–	﹤0.01%	4677
2022 Q2	$71K	Sell	23,853 -112,657	-83%	-$288K	﹤0.01%	4647
2022 Q1	$515K	Buy	136,510 +21,702	+19%	+$124K	﹤0.01%	4032
2021 Q4	$1.3M	Buy	114,808 +22,917	+25%	+$349K	﹤0.01%	3750
2021 Q3	$1.61M	Buy	+91,891	New	+$1.72M	﹤0.01%	3666

Other funds holding CYT

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BFO

Boston Family Office Boston, Massachusetts $1.5B AUM 11.68% 1-Year Est. Return

Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

State Street's CYT Position: Q1 2024 in Review

State Street sold out of Cyteir Therapeutics, Inc. Common Stock (CYT) in Q1 2024, closing a stake of 46,153 shares — an estimated $140K sold.

State Street first reported a position in CYT in Q3 2021 and held it in 10 quarters. The position peaked at $1.61M in Q3 2021. 4 funds tracked by Wall St. Rank hold CYT as of Q1 2024.

State Street reported no remaining Cyteir Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
State Street sold 46,153 Cyteir Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $140K.
State Street first reported a position in Cyteir Therapeutics, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
State Street's Cyteir Therapeutics, Inc. Common Stock position peaked at $1.61M in Q3 2021.
4 funds tracked by Wall St. Rank held Cyteir Therapeutics, Inc. Common Stock as of Q1 2024.

Based on State Street's 13F filing for Q1 2024, filed 15 May 2024.